Mevalonic acid

Mevalonic acid
Names
	Preferred IUPAC name (3R)-3,5-Dihydroxy-3-methylpentanoic acid
Identifiers
CAS Number	150-97-0 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:17710 ;
ChemSpider	388367 ;
KEGG	C00418 ;
PubChem CID	439230;
UNII	S5UOB36OCZ ;
CompTox Dashboard (EPA)	DTXSID801314151 DTXSID5040546, DTXSID801314151 ;
	InChI InChI=1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/t6-/m1/s1 Key: KJTLQQUUPVSXIM-ZCFIWIBFSA-N ; InChI=1/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/t6-/m1/s1 Key: KJTLQQUUPVSXIM-ZCFIWIBFBE;
	SMILES C[C@@](O)(CCO)CC(=O)O;
Properties
Chemical formula	C6H12O4
Molar mass	148.158 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Mevalonic acid (MVA) is a key organic compound in biochemistry; the name is a contraction of dihydroxymethylvalerolactone. The carboxylate anion of mevalonic acid, which is the predominant form in biological environments, is known as mevalonate and is of major pharmaceutical importance. Drugs like statins (which lower levels of cholesterol) stop the production of mevalonate by inhibiting HMG-CoA reductase.^[1]

^ Endo, A. (1992). "The discovery and development of HMG-CoA reductase inhibitors". Journal of Lipid Research. 33 (11): 1569–1582. PMID 1464741.

[1] Endo, A. (1992). "The discovery and development of HMG-CoA reductase inhibitors". Journal of Lipid Research. 33 (11): 1569–1582. PMID 1464741.

[1]